Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.
Phelps
S J
SJ
Department of Clinical Pharmacy, University of Tennessee, Memphis 38163.
Baldree
L A
LA
Boucher
B A
BA
Hogue
S L
SL
D000284:Administration, Oral; D000293:Adolescent; D017109:Akathisia, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D000755:Anemia, Sickle Cell / Q000150:complications; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis; D003937:Diagnosis, Differential; D016903:Drug Monitoring / Q000379:methods / Q000592:standards*; D005260:Female; D016231:Fluorescence Polarization Immunoassay; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy; D006212:Hallucinations / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007262:Infusions, Intravenous; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D011485:Protein Binding; D006435:Renal Dialysis; D012640:Seizures / Q000150:complications / Q000188:drug therapy*; D014462:Ultrafiltration
D010672:Phenytoin